SANUWAVE Health, Inc.
NASDAQ:SNWVMedical - Devices
+$0.18 today
- Market cap
- $51.01M
- Beta
- 1.34
- P/E (TTM)
- 5.0
- EPS (TTM)
- $1.87
Volume 0.04M
Average 0.11M
SNWV Net Income
Bottom-line profit, the starting point for calculating cash from operations.
SANUWAVE Health, Inc.NASDAQ: SNWV
Net Income · Q1 FY2026 · quarter ended Mar 2026
Net income dips below year-ago levels
Q1 FY2026 net income of $1.44M (cash outflow) fell 74.6% year over year, behind the +113.0% change in trailing-twelve-month net income. Sequentially, it fell 74.8% from the prior quarter.
Context
- Net income amounted to 26.8% of revenue in FY2025, down 69.3 pp from a year earlier.
- Net income increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net income reaches the consensus estimate from 1 analysts of -$726.6K (-106.2%) for the fiscal year ending Dec 2026, a slowdown from the +137.7% reported in FY2025.
Sources:Cash Flow Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$1.44M-74.8% QoQ
- Last fiscal yearDec 2025
- $11.81M+137.7% YoY
- LTMMar 2026
- $4.24M+113.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -74.6% | -124.4% | -49.8 pp |
| 1 year | +137.7% | -106.2% | -243.8 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Net Income history
USD · from the cash flow
- Latest · FY2025
- 11.81M USD
- Year-over-year change
- +137.7%
| Period | Period end | Net Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 11.81M | +137.7% |
| FY2024 | 2024-12-31 | (31.37M) | -21.6% |
| FY2023 | 2023-12-31 | (25.81M) | -150.7% |
| FY2022 | 2022-12-31 | (10.29M) | +62.2% |
| FY2021 | 2021-12-31 | (27.26M) | — |
Net Income vs competitors
How SNWV compares with its peers on the latest reported figures
- SNWV's LTM Mar 2026 net income of $4.24M is the smallest of the 11 companies compared; the peer median is $74.93M.
- Its year-over-year change of +113.0% is the 3rd highest of 11, against a peer median of +5.7%.
- Net income amounts to 9.6% of revenue for SNWV, versus a peer median of 71.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $136.85M | +947.5% | +42.7% | 1427.2% | |
| LTM Mar 2026 | $104.19M | +117.6% | +3.5% | 71.9% | |
| LTM Mar 2026 | $87.19M | +17.8% | — | 214.2% | |
| LTM Mar 2026 | $75.32M | -6.4% | -12.0% | 266.9% | |
| LTM Dec 2025 | $75.02M | +40.2% | -10.7% | 576.1% | |
| LTM Mar 2026 | $74.85M | -34.2% | -20.6% | 63.7% | |
| LTM Mar 2026 | $54.44M | -11.9% | +3.5% | — | |
| LTM Mar 2026 | $37.25M | -24.6% | -23.6% | 46.8% | |
| LTM Mar 2026 | $35.6M | +101.3% | — | 61.6% | |
| LTM Mar 2026 | $24.9M | -9.4% | -35.2% | 7.1% | |
| LTM Mar 2026 | $4.24M | +113.0% | — | 9.6% | |
| Peer median (excluding SNWV) | $74.93M | +5.7% | -11.3% | 71.9% | |
Competitors are the stored peer set for SNWV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (27.26M) | (10.29M) | (25.81M) | (31.37M) | 11.81M |
| Depreciation & Amortization | 1.24M | 952K | 1.03M | 1.15M | 1.28M |
| Deferred Income Tax | 28K | 2K | 4K | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 1.51M | 0 |
| Change in Working Capital | 9.93M | (1.12M) | (3.61M) | (2.9M) | (4.01M) |
| Accounts Receivables | (395K) | (1.75M) | (53K) | (486K) | (2.3M) |
| Inventory | 1.69M | (72K) | (2.8M) | (1.2M) | (2.28M) |
| Accounts Payables | 3.18M | (2.55M) | 1.55M | (1.42M) | (521K) |
| Other Working Capital | 5.46M | 3.25M | (2.3M) | 203K | 1.09M |
| Other Non-Cash Items | 9.66M | (6.71M) | 23.84M | 34.07M | (5.21M) |
| Operating Cash Flow | (6.41M) | (17.17M) | (4.54M) | 2.46M | 3.88M |
| Capital Expenditures | (529K) | 1.02M | 0 | (490K) | (1.94M) |
| Acquisitions (Net) | 0 | 332K | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | (1.02M) | 21K | 0 | 5.38M |
| Investing Cash Flow | (529K) | 332K | 21K | (490K) | 3.43M |
| Debt Repayment | 3.38M | 16.59M | 5.85M | (2.46M) | (6.14M) |
| Common Stock Issued | 0 | 100K | 0 | 10.3M | 556K |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.74M | 695K | (639K) | (1.49M) | 0 |
| Financing Cash Flow | 5.12M | 17.38M | 5.21M | 6.35M | (5.59M) |
| Effect of Forex Changes | (1K) | (13K) | (50K) | 121K | 0 |
| Net Change in Cash | (1.82M) | 534K | 644K | 8.44M | 1.72M |
| Free Cash Flow | (6.94M) | (16.15M) | (4.54M) | 1.97M | 1.93M |
SANUWAVE Health, Inc.
NASDAQ:SNWV
Intrinsic Alpha fair value
Locked
Current Price
$5.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.